Handelsbanken Fonder’s Cogent Biosciences COGT Stock Holding History

Handelsbanken Fonder’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	+44,600	New	+$1.56M	﹤0.01%	876

Other funds holding COGT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Handelsbanken Fonder's COGT Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Cogent Biosciences (COGT) in Q2 2026: 44,600 shares worth $1.73M. The stake represents ﹤0.01% of the portfolio and ranks #876 among its holdings.

17 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Handelsbanken Fonder held 44,600 shares of Cogent Biosciences worth $1.73M as of Q2 2026.
Cogent Biosciences was a new Handelsbanken Fonder position in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #876 holding.
17 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.